Journal Home
Search for

Volume 95, Issue 3, Pages 188-198 (1 June 2008)


View previous. 3 of 13 View next.

Further evidence of an association between adolescent bipolar disorder with smoking and substance use disorders: A controlled study

Timothy E. WilensabCorresponding Author Informationemail address, Joseph Biedermanab, Joel J. Adamsona, Aude Henina, Stephanie Sgambatia, Martin Gignacc, Robert Sawtellea, Alison Santrya, Michael C. Monuteauxab

Received 5 July 2007; received in revised form 20 November 2007; accepted 26 December 2007.

Abstract 

Although previous work suggests that juvenile onset bipolar disorder increases risk for substance use disorders and cigarette smoking, the literature on the subject is limited. We evaluated the association of risk for substance use disorders and cigarette smoking with bipolar disorder in adolescents in a case–control study of adolescents with bipolar disorder (n=105, age 13.6±2.5 years [mean]; 70% male) and without bipolar disorder (“controls”; n=98, age 13.7±2.1 years; 60% male). Rates of substance use and other disorders were assessed with structured interviews (KSADS-E for subjects younger than 18, SCID for 18-year-old subjects). Bipolar disorder was associated with a significant age-adjusted risk for any substance use disorder (hazard ratio[95% confidence interval]=8.68[3.02 25.0], χ2=16.06, p<0.001, df=1), alcohol abuse (7.66 [2.20 26.7], χ2=10.2, p=0.001, df=1), drug abuse (18.5 [2.46 139.10], χ2=8.03, p=0.005, df=1) and dependence (12.1 [1.54 95.50], χ2=5.61, p=0.02, df=1), and cigarette smoking (12.3 [2.83 53.69], χ2=11.2, p<0.001, df=1), independently of attention deficit/hyperactivity disorder, multiple anxiety, and conduct disorder (CD). The primary predictor of substance use disorders in bipolar youth was older age (BPDSUD versus BPD+SUD, logistic regression: χ2=89.37, p<0.001). Adolescent bipolar disorder is a significant risk factor for substance use disorders and cigarette smoking, independent of psychiatric comorbidity. Clinicians should carefully screen adolescents with bipolar disorder for substance and cigarette use.

a Massachusetts General Hospital, Pediatric Psychopharmacology Unit, Boston, MA 02114, USA

b Harvard Medical School, Department of Psychiatry, Cambridge, MA 02115, USA

c Institute Philippe Pinel, Université de Montréal, Montréal, Qc H3C 3J7, Canada

Corresponding Author InformationCorresponding author at: Massachusetts General Hospital, Pediatric Psychopharmacology Unit, 32 Fruit Street, YAW 6A, Boston, MA 02114, USA. Tel.: +1 617 726 1731; fax: +1 617 724 3742.

 Funding Source: This study was financially supported by NIH RO1 DA12945 (TW) and K24 DA016264 (TW).

PII: S0376-8716(08)00050-1

doi:10.1016/j.drugalcdep.2007.12.016


View previous. 3 of 13 View next.